Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.
The company is guiding for first quarter revenue to be in a range of $12.2 billion to $13.2 billion, which is shy of a Street estimate of $14.2 billion, according to data from Benzinga Pro. Intel sees first quarter earnings per share hitting 13 cents, which is below a Street estimate of 33 cents per share.
Intel shares dipped 10.7% to $44.23 on Friday.
Here are some other stocks moving in today's mid-day session.
Gainers
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) jumped 146% to $20.76 after the company announced data from the first-in-human clinical study of CRB-701 is being presented as a poster by its development partner CSPC Pharmaceutical at ASCO GU 2024.
Inspire Veterinary Partners, Inc. (NASDAQ: IVP) jumped 121% to $0.4220 after jumping over 22% on Thursday.
Aclarion, Inc. (NASDAQ: ACON) shares climbed 69.7% to $3.1650.
Panbela Therapeutics, Inc. (NASDAQ: PBLA) surged 32% to $4.31. Panbela Therapeutics has reached 50% enrollment in ASPIRE trial of ivospemin plus gemcitabine and nab-paclitaxel combo in first-line treatment of metastatic pancreatic cancer.
Meiwu Technology Company Limited (NASDAQ: WNW) gained 26.5% to $10.55.
AppFolio, Inc. (NASDAQ: APPF) gained 25.7% to $219.23 after the company reported better-than-expected fourth-quarter financial results and issued guidance.
Vera Therapeutics, Inc. (NASDAQ: VERA) jumped 20.6% to $30.54. Raymond James analyst Steven Seedhouse upgraded Vera Therapeutics from Outperform to Strong Buy and raised the price target from $29 to $37.
Cyngn Inc. (NASDAQ: CYN) surged 19.8% to $0.2575. Cyngn shares jumped over 17% on Thursday after the company disclosed a strategic shift to Nvidia AI computers that will transform the technology powering its fleet of DriveMod autonomous industrial ...
Benzinga
